{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:57:29Z","timestamp":1794938249879,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/aog.0000000000000759","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T05:24:01Z","timestamp":1428297841000},"page":"1224-1235","source":"Crossref","is-referenced-by-count":128,"title":["Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy"],"prefix":"10.1097","volume":"125","author":[{"given":"Catherine G.","family":"Coughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Yonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","article-title":"Use and safety of antipsychotic drugs during pregnancy.","volume":"15","author":"Einarson","year":"2009","journal-title":"J Psychiatric Pract"},{"key":"R2-33-20210126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/schbul\/sbn107","article-title":"Antipsychotic therapy during early and late pregnancy. A systematic review.","volume":"36","author":"Gentile","year":"2010","journal-title":"Schizophr Bull"},{"key":"R3-33-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2004.06.026","article-title":"Fertility and pregnancy in women with psychotic disorders.","volume":"119","author":"Howard","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R4-33-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2850.2009.01481.x","article-title":"Antipsychotics in pregnancy.","volume":"17","author":"McCauley-Elsom","year":"2010","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"R5-33-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":". Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.","volume":"16","author":"Toh","year":"2013","journal-title":"Arch Womens Ment Health"},{"key":"R6-33-20210126","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/pds.3366","article-title":". Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.","volume":"22","author":"Epstein","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R7-33-20210126","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":". Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R9-33-20210126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/ajp.153.5.592","article-title":"Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines.","volume":"153","author":"Altshuler","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R10-33-20210126","first-page":"1001","article-title":"ACOG Practice Bulletin No. 92. American College of Obstetricians and Gynecologists.","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R11-33-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00048670903487217","article-title":"Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.","volume":"44","author":"Galbally","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"R12-33-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.bp.112.117556","article-title":"Fetal antipsychotic exposure in a changing landscape: seeing the future.","volume":"202","author":"Abel","year":"2013","journal-title":"Br J Psychiatry"},{"key":"R14-33-20210126","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/md10112535","article-title":"Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.","volume":"10","author":"Russell","year":"2012","journal-title":"Mar Drugs"},{"key":"R15-33-20210126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R17-33-20210126","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","article-title":"Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects.","volume":"69","author":"Boden","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"R18-33-20210126","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy.","volume":"6","author":"Kallen","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"R19-33-20210126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome.","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R20-33-20210126","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-9378(77)90028-X","article-title":"Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.","volume":"128","author":"Shapiro","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R21-33-20210126","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9378(77)90029-1","article-title":"Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.","volume":"128","author":"Slone","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R22-33-20210126","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","article-title":"Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.","volume":"192","author":"Newham","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R23-33-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420150108","article-title":"Possible teratogenic effect of phenothiazines in human beings.","volume":"15","author":"Rumeau-Rouquette","year":"1977","journal-title":"Teratology"},{"key":"R24-33-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4088\/JCP.v66n0307","article-title":". Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.","volume":"66","author":"Diav-Citrin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R26-33-20210126","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":". Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R27-33-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":". Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.","volume":"33","author":"Habermann","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"R28-33-20210126","first-page":"453","article-title":"Atypical antipsychotic agents in early pregnancy.","volume":"20","author":"Paulus","year":"2005","journal-title":"Reprod Toxicol"},{"key":"R29-33-20210126","first-page":"55","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference Schizophr R","volume":"116","author":"Lin","year":"2010","journal-title":"es"},{"key":"R30-33-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1471-0528.12567","article-title":". Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study.","volume":"121","author":"Vigod","year":"2014","journal-title":"BJOG"},{"key":"R32-33-20210126","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":". Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"R33-33-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","article-title":"Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.","volume":"25","author":"Goncalves","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"R34-33-20210126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia.","volume":"93","author":"Brown","year":"2011","journal-title":"Prog Neurobiol"},{"key":"R35-33-20210126","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.","volume":"67","author":"Grote","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"R36-33-20210126","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Increased rate of major malformations in offspring exposed to valproate during pregnancy.","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"key":"R37-33-20210126","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2174\/138161206776389804","article-title":"Teratogenic and developmental effects of lithium.","volume":"12","author":"Giles","year":"2006","journal-title":"Curr Pharm Des"},{"key":"R38-33-20210126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032813-153626","article-title":"Antidepressant use in pregnant and postpartum women.","volume":"10","author":"Yonkers","year":"2014","journal-title":"Annu Rev Clin Psychol"},{"key":"R39-33-20210126","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.4088\/JCP.12r07968","article-title":". The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis.","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"R40-33-20210126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1047-2797(00)00209-X","article-title":"Validation of birth certificate data. A study of women in New Jerseys HealthStart program.","volume":"11","author":"Reichman","year":"2001","journal-title":"Ann Epidemiol"},{"issue":"suppl 2","key":"R41-33-20210126","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use.","volume":"6","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R42-33-20210126","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":". Antipsychotic-induced weight gain: a comprehensive research synthesis.","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R43-33-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","article-title":"Atypical antipsychotics and glucose dysregulation: a systematic review.","volume":"71","author":"Jin","year":"2004","journal-title":"Schizophr Res"},{"key":"R44-33-20210126","first-page":"1","article-title":"Bombard JM; Centers for Disease Control and Prevention (CDC). Trends in smoking before, during, and after pregnancyPregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005.","volume":"58","author":"Tong","year":"2009","journal-title":"MMWR Surveill Summ"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:46:36Z","timestamp":1691563596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201505000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000759","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}